title: Development of antidiabetic nanomedicine from stevioside.
abstract: Stevioside, a non-caloric sweetener has huge therapeutic potential as an antidiabetic biomolecule. Stevioside nano-bioconjugated on PEG-PLA nanoparticles of size 150-170 nm showed the initial burst phase followed by the slow controlled release of 2 h and 21 days respectively.
authors.affiliation: Biotechnology Division, Institute of Himalayan Bioresource Technology (Council of Scientific and Industrial Research, India), Palampur 176061, India.
authors.forename: Subhash C
authors.initials: SC
authors.lastname: Yadav
authors.forename: Sudesh K
authors.initials: SK
authors.lastname: Yadav
authors.forename: Anil
authors.initials: A
authors.lastname: Sood
authors.forename: Mohit
authors.initials: M
authors.lastname: Sharma
authors.forename: Bikram
authors.initials: B
authors.lastname: Singh
mesh_terms: D004058:Diffusion; D045786:Diterpenes, Kaurane / Q000737:chemistry* / Q000627:therapeutic use; D004339:Drug Compounding / Q000379:methods; D005960:Glucosides / Q000737:chemistry* / Q000627:therapeutic use; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000627:therapeutic use; D053769:Nanocapsules / Q000737:chemistry* / Q000648:ultrastructure*; D010316:Particle Size
chemical_list: D045786:Diterpenes, Kaurane; D005960:Glucosides; D007004:Hypoglycemic Agents; D053769:Nanocapsules; C012043:stevioside